Eric Hong

Title: **The Innovations of Eric Hong: A Leading Inventor in Coagulation Assays**

Introduction

Eric Hong, based in Toronto, Canada, is an accomplished inventor with a portfolio of four patents to his name. His work is primarily focused on advancing technologies related to coagulation assays, demonstrating a significant impact on the field of fluid sample analysis.

Latest Patents

Among Eric's most notable innovations are two recent patents concerning microfabricated devices equipped with micro-environment sensors. The first patent details a sample analysis cartridge designed for assaying coagulation in fluid samples. This device includes an inlet chamber for receiving biological samples and a conduit that is fluidically connected to the inlet chamber. The conduit features advanced sensors, including a micro-environment prothrombin time (PT) sensor, and a micro-environment activated partial thromboplastin time (aPTT) sensor.

The second patent focuses on analytical testing devices that utilize micro-environment sensors for coagulation assays. This invention enhances the efficiency of performing multiple coagulation assays within a single point-of-care test cartridge. The design incorporates sensors that include at least one transducer coated with a specialized polymer layer, which contains a thrombin-cleavable peptide with a detectable moiety.

Career Highlights

Eric Hong has made significant contributions to the medical device industry through his role at Abbott Point of Care Inc., where he actively develops innovative technologies aimed at improving healthcare diagnostics. His work emphasizes the integration of micro-fabrication techniques with biomedical applications, positioning him as a key player in the field.

Collaborations

Throughout his career, Eric has had the opportunity to collaborate with talented individuals such as Tian-Xian Zhao and Anjulia Chiu-Yuk Wong. These collaborations have been instrumental in advancing research and development efforts within their organization, resulting in cutting-edge solutions for coagulation testing.

Conclusion

Eric Hong's dedication to innovation in coagulation assays has led to groundbreaking inventions that can potentially transform point-of-care testing. Through his continued efforts at Abbott Point of Care Inc. and collaborations with his colleagues, Eric is positioned as a prominent inventor driving advancements in medical diagnostics. As his work evolves, it is clear that Eric Hong will remain an influential figure in the realm of health technology.